- Rare disease specialist Shire has filed its first submission to the US Food & Drug Administration for the company's new plasma manufacturing facility in Covington, Georgia.

The facility is expected to add c30% capacity to the company's internal network once fully operational.

Shire hopes to start commercial production in 2018.

At 12:42pm: [LON:SHP] Shire PLC share price was +33p at 3913.5p

Story provided by